FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
Evofem Biosciences (NASDAQ: EVFM) reported Q1 EPS of ($0.40), $0.08 worse than the analyst estimate of ($0.32).
"We are now less than three weeks away from the PDUFA date for Phexxi and the potential to deliver the first non-hormonal contraceptive innovation in decades. We are... More

